IL6 and breast carcinoma: Furthermore, miR-146b inhibits NF-κB-mediated production of IL-6, a proinflammatory cytokine associated with cancer, STAT3 activity, and IL-6/STAT3-driven breast cancer cells migration and invasion [53].